Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized withdrawal study of BIIB074 in trigeminal neuralgia
2016-002473-35Phase 3Completed
- Sponsor
- Biogen
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in trigeminal neuralgia (TN) comparing BIIB074 continuation arm with Placebo withdrawal arm (2 arms). Primary endpoint: Time to loss of therapeutic response. Started Dec 2016; status: completed.
02
Drugs
vixotrigine
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on 2016-002473-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002473-35.